Posted: December 22nd, 2017

Eli Lilly and Company and Eli Lilly Danmark A/S (“Lilly”) v. Fresenius Kabi AB v/Fresenius Kabi and Fresenius Kabi Oncology Plc. (“Fresenius Kabi”), the Danish Maritime and Commercial High Court, Case number A-19-17, 8 December 2017 The case concerns the infringement of Lilly’s patent DK/EP 1 313 508 (“DK/EP ‘508”) which relates to the use […]


UK – Curt G Joa v. Fameccanica Data

Posted: May 24th, 2017

Curt G Joa, Inc v Fameccanica Data SpA, UK, Intellectual Property Enterprise Court, Hacon HHJ, 24 May 2017 This case concerned a patent for “disposable absorbent garments”, including nappies/diapers and adult incontinence garments. By the time the case came to trial, the patentee had made both unconditional and conditional applications to amend the claims of […]


NL – HTW v. Permavoid

Posted: January 5th, 2017

HTW Infiltratietechniek B.V. v. Permavoid Limited, Court of Appeal of the Hague, the Netherlands, 27 December 2016, Case number C/09/456139 / HA ZA 13-1362 Permavoid is the holder of European patent EP 1 311 727 B1 for ‘a pavement with structural module’. All claims of EP ‘727 are directed to a ‘vehicular trafficked pavement structure’. […]


UK – MSD v. Shionogi

Posted: December 21st, 2016

Merck Sharp and Dohme Limited v Shionogi & Co. Limited, High Court of England and Wales (Arnold J), 25 November 2015, Neutral Citation Number [2016] EWHC 2989 (Pat) The claimant, Merck, sought revocation of Shionogi’s EP(UK) 1 422 218. The defendant, Shionogi, counterclaimed for infringement by Merck’s integrase inhibitor raltegravir, marketed as Isentress. Shionogi made […]


UK – Sony Communications International v. SSH Communications Security Corporation

Posted: October 24th, 2016

Sony Communications International AB and others v SSH Communications Security Corporation and others, UK Patents Court, Roger Wyand QC, 10 October 2016, Neutral Citation Number: [2016] EWHC 2359 (Ch) In this action Sony sought to revoke SSH’s patent, EP (UK) 2 254 311. This patent related to an aspect of accessing wide area networks (WANs) […]


UK – Warner-Lambert v. Actavis

Posted: October 17th, 2016

Warner-Lambert Company LLC v (1) Generics (UK) Limited (trading as Mylan), (2) Actavis Group PTC EHF, (3) Actavis UK Limited and (4) Caduceus Pharma Limited, England and Wales Court of Appeal (Floyd, Pattern and Kitchin LJJ), London UK, 13 October 2016, Neutral Citation Number: [2016] EWCA Civ 1006 The Court of Appeal dismissed Warner-Lambert’s appeal […]


ES – Astrazeneca v. Laboratorios Alter

Posted: February 15th, 2016

On 21st December 2015, The Supreme Court handed down a decision in the case of AstraZeneca AB & others v Laboratorios Alter and & others (EDJ 2015/244058). AstraZeneca had filed an action against several generic companies for infringement of an SPC for the product quetaipina: The SPC’s basic patent was EP 228. EP 228 was […]


UK – Mylan v. Warner-Lambert / Abuse

Posted: December 9th, 2015

Generics (UK) Limited trading as Mylan v Warner-Lambert Company LLC, High Court of England and Wales (Arnold J), London, UK, 25 November 2015, Neutral Citation Number: [2015] EWHC 3370 (Pat) Arnold J has struck out Warner-Lambert’s conditional application to amend a patent held invalid at first instance, and which was subject to ongoing appeal proceedings. […]


NO – Genentech v. Hospira

Posted: December 9th, 2015

Genentech Inc. vs. Hospira UK Ltd, Hospira Nordic AB, Borgarting Court of Appeal, Norway, 24 April 2015, Case No. LB-2014-66504 On 24 April 2015 Borgarting Court of Appeal rendered its decision in a case between Genentech (appellants) and Hospira (respondent) regarding parts of the claims of Genentech’s patent NO 323557. The relevant patent claims concerned […]